FDA grants orphan drug designation for Disc’s PV treatment
This designation is a significant milestone for the company as it aims to develop treatments for rare hematologic conditions. DISC-3405, an anti-Transmembrane Serine Protease 6 (TMPRSS6) monoclonal antibody,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.